 |
|
Study details strategy for boosting ranks of black HIV/AIDS researchers
April 01, 2009African Americans, who make up 13 percent of the U.S. population, are disproportionately affected by AIDS, accounting for nearly 49 percent of newly diagnosed HIV/AIDS cases nationwide. About 500,000 African Americans are now living with HIV/AIDS.
Yet there are very few African American HIV/AIDS researchers, due to historical, social and other factors that prevent them from training in the biomedical, behavioral and social aspects of HIV/AIDS research.
In response to the shortage, researchers from the UCLA Center for Culture, Trauma and Mental Health Disparities and the UCLA AIDS Institute have developed a series of recommendations that could reverse the trend and lead more African American researchers into the field. The recommendations are outlined in an article published in a supplement to the April issue of the American Journal of Public Health (available online at www.ajph.org/cgi/content/full/99/S1/S48).
"The most effective behavior-change policies allow for individuals to be part of the solution and not the problem," said lead author Dr. Gail Wyatt, professor of psychiatry and biobehavioral sciences at the Semel Institute for Neuroscience and Human Behavior at UCLA. "We need African American experts who are at the forefront of HIV/AIDS prevention."
The researchers have identified four institutional factors, as well as two individual factors, that limit the number of African Americans pursuing HIV/AIDS research.
Institutional factors include limitation of early career decisions and a lack of exposure to research, research socialization and mentoring. For example, African American college students often don't receive research training early in their careers, so they may not be experienced in pulling together a team of strong research collaborators. In addition, some department chairs may think it is "too late" for doctoral graduates to move into a research career, and there are few senior African Americans to mentor and encourage a new generation of African American HIV/AIDS investigators.
Compounding this situation are individual factors. Given the scarcity of role models, African American students may have negative perceptions about their own competence as HIV/AIDS investigators, and there is limited support for culturally congruent research.
To boost the ranks of African American HIV/AIDS researchers, the study authors make the following seven recommendations to universities and other institutions of higher learning, and private and government funders of research and training:
* Fund research that encourages partnerships with historically African American and minority-serving institutions, such as the National Medical Association and the Association of Black Psychologists, so that clinically trained professionals can participate in and learn more about HIV/AIDS research.
* Provide for retraining of established researchers who wish to shift their focus to HIV/AIDS.
* Continue to offer loan-repayment programs for graduate education.
* Incorporate mentorships into graduate and professional training programs.
* Encourage universities and training programs to recognize mentors whose students pursue HIV/AIDS research, and establish awards that recognize the work of African American investigators in the field.
* Develop and use culturally congruent theories and measures in HIV/AIDS research.
* Require training in cultural competence for federal staff, reviewers and mentors.
"HIV/AIDS research conducted by highly trained African Americans should be the norm and not the exception," the authors conclude. "Such researchers add an important voice and level of expertise to HIV prevention that can only be enhanced by implementing programs to increase the representation of African American investigators in NIH-funded research. A concerted effort to remove barriers to funding and career trajectories to ensure that HIV/AIDS research addresses the most affected populations is needed."
University of California - Los Angeles
"The most effective behavior-change policies allow for individuals to be part of the solution and not the problem," said lead author Dr. Gail Wyatt, professor of psychiatry and biobehavioral sciences at the Semel Institute for Neuroscience and Human Behavior at UCLA. "We need African American experts who are at the forefront of HIV/AIDS prevention."
The researchers have identified four institutional factors, as well as two individual factors, that limit the number of African Americans pursuing HIV/AIDS research.
Institutional factors include limitation of early career decisions and a lack of exposure to research, research socialization and mentoring. For example, African American college students often don't receive research training early in their careers, so they may not be experienced in pulling together a team of strong research collaborators. In addition, some department chairs may think it is "too late" for doctoral graduates to move into a research career, and there are few senior African Americans to mentor and encourage a new generation of African American HIV/AIDS investigators.
Compounding this situation are individual factors. Given the scarcity of role models, African American students may have negative perceptions about their own competence as HIV/AIDS investigators, and there is limited support for culturally congruent research.
To boost the ranks of African American HIV/AIDS researchers, the study authors make the following seven recommendations to universities and other institutions of higher learning, and private and government funders of research and training:
* Fund research that encourages partnerships with historically African American and minority-serving institutions, such as the National Medical Association and the Association of Black Psychologists, so that clinically trained professionals can participate in and learn more about HIV/AIDS research.
* Provide for retraining of established researchers who wish to shift their focus to HIV/AIDS.
* Continue to offer loan-repayment programs for graduate education.
* Incorporate mentorships into graduate and professional training programs.
* Encourage universities and training programs to recognize mentors whose students pursue HIV/AIDS research, and establish awards that recognize the work of African American investigators in the field.
* Develop and use culturally congruent theories and measures in HIV/AIDS research.
* Require training in cultural competence for federal staff, reviewers and mentors.
"HIV/AIDS research conducted by highly trained African Americans should be the norm and not the exception," the authors conclude. "Such researchers add an important voice and level of expertise to HIV prevention that can only be enhanced by implementing programs to increase the representation of African American investigators in NIH-funded research. A concerted effort to remove barriers to funding and career trajectories to ensure that HIV/AIDS research addresses the most affected populations is needed."
University of California - Los Angeles
HIV Current Events and HIV News RSSMany pregnant women avoid HIV screening in Africa
'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission.
An atomic-level look at an HIV accomplice
Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity.
New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Hoping for a fluorescent basket case
Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem.
Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design
A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.
U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat
Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide.
1930s drug slows tumor growth
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease.
Indiana U. at APHA: Studies about why men and women use lubricants during sex
An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex.
More HIV Current Events and HIV News Articles
 |
100 Questions and Answers About HIV and AIDS by Joel Gallant (Author) |
 |
The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The) by Brett Grodeck (Author), M.D. Daniel S. Berger (Foreword) This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans. |
 |
HIV Essentials 2010 by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author) HIV Essentials 2010 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management and prevention of HIV infection and its complications. Topics include: HIV diagnosis, evaluation, treatment and prevention; Opportunistic infections and other HIV Complications; Treatment of HIV and pregnancy; Antiretroviral drug summaries; Post-exposure Prophylaxis; New section to each drug summary called "How Supplied" describes the commercially available dosage forms for all the ARV's |
 |
Living with HIV: A Patient's Guide by Mark Cichocki (Author) This helpful guide offers a wealth of information for individuals who have been diagnosed with HIV and for people caring for HIV positive friends and loved ones. It covers the entire HIV lifespan, from prevention to diagnosis and beyond. Valuable tips help the reader make the best decision when choosing a doctor, finding and adhering to the right medication regimen, and, if necessary, making end-of-life plans. All aspects of HIV/AIDS are discussed, including opportunistic and associated infections, dental care, exercise and nutrition, substance use and abuse, and emotional treatment. |
 |
Home Access HIV - 1 Express Test System - 1 ea by Home Access Next Day Results* Contains one single-use sample collection kit |
 |
HIV and the Pathogenesis of AIDS, 3rd Edition by Jay A. Levy (Author) The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed. Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and... |
 |
The Naked Truth: Young, Beautiful, and (HIV) Positive by Marvelyn Brown (Author), Courtney Martin (Author) The surprisingly hopeful story of how a straight, nonpromiscuous, everyday girl contracted HIV and how she manages to stay upbeat, inspired, and more positive about life than ever before At nineteen years of age, Marvelyn Brown was lying in a stark white hospital bed at Tennessee Christian Medical Center, feeling hopeless. A former top track and basketball athlete, she was in the best shape of her life, but she was battling a sudden illness in the intensive care unit. Doctors had no idea what was going on. It never occurred to Brown that she might be HIV positive. Having unprotected sex with her Prince Charming had set into swift motion a set of circumstances that not only landed her in the fight of her life, but also alienated her from her community. Rather than give... |
 |
Absolutely Positive Directed By: Peter Adair Also With: Janet Cole (Cinematographer), Peter Adair (Cinematographer), Peter Adair (Writer) Ten years following its ground-breaking debut at Sundance, the landmark film that first humanized the face of AIDS is now available in this special 10th Anniversary Edition. Simultaneously heart-wrenching and life affirming, ABSOLUTELY POSITIVE is an hon |
 |
HIV/AIDS: A Very Short Introduction (Very Short Introductions) by Alan Whiteside (Author) HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means... |
 |
Global HIV/AIDS Medicine by Paul A. Volberding MD (Editor), Merle A. Sande MD (Editor), Joep Lange MD (Editor), Warner C. Greene MD PhD (Editor), Joel E. Gallant MD MPH (Editor) HIV/AIDS management poses many different challenges around the world, and the therapies available in the West are often not economically feasible in developing countries. This new book is the first to address the myriad of clinical difficulties faced by health practitioners worldwide in managing HIV/AIDS. Edited by the same authorities responsible for the highly respected reference "The Medical Management of AIDS," with Associate Editors that include the President of the International AIDS Society and a preeminent opinion leader in the fight against AIDS in Africa, and authored by a "who's who" of current global experts on HIV and AIDS medicine, this visionary text presents all the practical, indispensable information that clinicians everywhere need to offer their patients the best... |
| © 2009 BrightSurf.com |